Pathstone Family Office, LLC Cognition Therapeutics Inc Transaction History
Pathstone Family Office, LLC
- $15.6 Billion
- Q3 2023
A detailed history of Pathstone Family Office, LLC transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Pathstone Family Office, LLC holds 2,205,377 shares of CGTX stock, worth $1.3 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,205,377
Previous 2,205,377
-0.0%
Holding current value
$1.3 Million
Previous $4.04 Million
21.31%
% of portfolio
0.02%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding CGTX
# of Institutions
50Shares Held
13.4MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX6MShares$3.54 Million4.39% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.24MShares$731,3440.0% of portfolio
-
Sigma Planning Corp Ann Arbor, MI614KShares$362,5490.01% of portfolio
-
Voss Capital, LLC Houston, TX500KShares$295,0000.03% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$295,0000.0% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $13.4M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...